Results 61 to 70 of about 141,567 (268)

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Cote d\u27Ivoire [PDF]

open access: yes, 2019
BackgroundA single co-administered dose of ivermectin (IVM) plus diethylcarbamazine (DEC) plus albendazole (ALB), or triple-drug therapy, was recently found to be more effective for clearing microfilariae (Mf) than standard DEC plus ALB currently used ...
Bjerum, Catherine M   +9 more
core   +4 more sources

Interruption of lymphatic filariasis transmission in Manaus, a former focus of Wuchereria bancrofti in the Western Brazilian Amazon

open access: yesRevista Panamericana de Salud Pública, 2021
Objective. To confirm the absence of Wuchereria bancrofti autochthonous cases in Manaus, a former focus of lymphatic filariasis in the Western Brazilian Amazon. Methods.
Marilaine Martins   +2 more
doaj   +1 more source

Financial burden impact quality of life among lymphatic Filariasis patients

open access: yesBMC Public Health, 2020
Background Human lymphatic filarial pathology is the leading cause of disability and poverty among people living with the infection. The second goal of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) is to manage the disease’s morbidity to
Samuel O Asiedu   +5 more
semanticscholar   +1 more source

Factors associated with the performance and cost-effectiveness of using lymphatic filariasis transmission assessment surveys for monitoring soil-transmitted helminths: a case study in Kenya. [PDF]

open access: yes, 2015
Transmission assessment surveys (TAS) for lymphatic filariasis have been proposed as a platform to assess the impact of mass drug administration (MDA) on soil-transmitted helminths (STHs).
Assefa   +34 more
core   +1 more source

Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis

open access: yesInternational Health, 2020
Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations ...
A. Krentel   +5 more
semanticscholar   +1 more source

Most of the response elicited against Wolbachia surface protein in filarial nematode infection is due to the infective larval stage [PDF]

open access: yes, 2004
Immune responses to the intracellular Wolbachia bacteria of filarial nematodes are thought to contribute to the pathologic process of filarial infection.
Allen, Judith E   +7 more
core   +1 more source

Achievements and challenges of lymphatic filariasis elimination in Sierra Leone

open access: yesPLoS Neglected Tropical Diseases, 2020
Background Lymphatic filariasis (LF) is targeted for elimination in Sierra Leone. Epidemiological coverage of mass drug administration (MDA) with ivermectin and albendazole had been reported >65% in all 12 districts annually. Eight districts qualified to
Y. Bah   +9 more
semanticscholar   +1 more source

Filariasis of the Axilla in a Patient Returning from Travel Abroad: A Case Report [PDF]

open access: yes, 2012
Background: The term filariasis comprises a group of parasitic infections caused by helminths belonging to different genera in the superfamily Filaroidea.
Alkadhi H   +20 more
core   +1 more source

Caring for patients in the global programme to eliminate lymphatic filariasis

open access: yesInternational Health, 2020
Clinical lymphatic filariasis (LF) is a debilitating, disfiguring medical condition with severe psychosocial consequences for patients and their families.
C. Mackenzie, S. Mante
semanticscholar   +1 more source

Genital manifestations of tropical diseases [PDF]

open access: yes, 2004
Genital symptoms in tropical countries and among returned travellers can arise from a variety of bacterial, protozoal, and helminthic infections which are not usually sexually transmitted.
Richens, J
core   +2 more sources

Home - About - Disclaimer - Privacy